Glutamate-related biomarkers in drug development for disorders of the nervous system : workshop summary /

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range o...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Collectivité auteur: Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders
Autres auteurs: Pankevich, Diana E., 1975-, Altevogt, Bruce M., Davis, Miriam (Medical writer)
Format: Électronique eBook
Langue:Inglés
Publié: Washington, D.C. : National Academies Press, ©2011.
Sujets:
Biochemical markers > Congresses.
Drug development > Congresses.
Nervous system > Diseases > Congresses.
Neuropharmacology > Congresses.
Biomarkers, Pharmacological
Central Nervous System Diseases > diagnosis
Central Nervous System > drug effects
Drug Discovery
Glutamic Acid > adverse effects
Neuropharmacology > methods
Marqueurs biologiques > Congrès.
Médicaments > Développement > Congrès.
Système nerveux > Maladies > Congrès.
Neuropharmacologie > Congrès.
MEDICAL > Allied Health Services > Medical Technology.
MEDICAL > Biotechnology.
MEDICAL > Family & General Practice.
MEDICAL > Lasers in Medicine.
TECHNOLOGY & ENGINEERING > Biomedical.
Biochemical markers
Drug development
Nervous system > Diseases
Neuropharmacology
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Accès en ligne:Texto completo

Internet

Texto completo

Items no disponibles

Informations d'exemplaires de

Documents similaires